RCAMU
PRAH
Rothschild & Co Asset Management US’s PRA Health Sciences, Inc. PRAH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-200,130
| Closed | -$16.6M | – | 358 |
|
|
2020
Q1 | $16.6M | Sell |
200,130
-17,529
| -8% | -$1.46M | 0.26% | 148 |
|
|
2019
Q4 | $24.2M | Sell |
217,659
-9,884
| -4% | -$1.1M | 0.25% | 173 |
|
|
2019
Q3 | $22.6M | Sell |
227,543
-4,823
| -2% | -$479K | 0.24% | 176 |
|
|
2019
Q2 | $23M | Sell |
232,366
-1,378
| -0.6% | -$137K | 0.25% | 175 |
|
|
2019
Q1 | $25.8M | Buy |
233,744
+10,148
| +5% | +$1.12M | 0.28% | 136 |
|
|
2018
Q4 | $20.6M | Sell |
223,596
-1,735
| -0.8% | -$160K | 0.25% | 157 |
|
|
2018
Q3 | $24.8M | Sell |
225,331
-21,175
| -9% | -$2.33M | 0.25% | 164 |
|
|
2018
Q2 | $23M | Sell |
246,506
-64,400
| -21% | -$6.01M | 0.25% | 166 |
|
|
2018
Q1 | $25.8M | Sell |
310,906
-2,134
| -0.7% | -$177K | 0.29% | 153 |
|
|
2017
Q4 | $28.5M | Buy |
+313,040
| New | +$28.5M | 0.3% | 136 |
|